Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		550000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	41.3	9.9	3.9	57.0	9.7	0.2	23.1	0.8	4.1	56.4	3.1	36.5	5.3	49.5	10.7	35.1	46.9	97.9	44.5	3.8	26.6	12.2	7.8	68.7	25.9	3.4	5.7	89.4	12.7	3.0	4.7	51.9	7.3	8.7	56.2	57.5	13.7	12.3	6.7	14.0	15.4	72.0	5.6	12.4	25.5	17.1	6.7	7.9	25.0	41.1	39.9	96.7	23.7	9.1	1.3	0.3	0.1	0.0	37.0	437.3	0.4	91.9	90.2	171.4	79.9	0.0	0.2	0.9	0.4	25.0	0.3	0.0	0.1	1.0	278.2	0.8	0.7	2.4	1.6	0.0	23.7	0.5	0.1	26.6	1.0	840.8	818.4	3.6	267.1	0.0	0.5	1.3	158.6	0.0	0.5	0.3	0.1	0.0	87.5	0.4	0.7	0.7	54.0	0.2	0.2	0.6	0.0	0.6	0.1	0.8	0.3	0.1	1405.8	37.7	0.4	311.0	19.7	1.0	0.0	0.0	43.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	0.8	4.1	3.8	26.6	3.4	5.7	7.3	5.6	6.7	9.1	9.1	57.7	5.5	26.1	0.3	15.9	1.5	5.8	4.6	1.2	0.6	1.8	9.7	10.0	39.8	18.4	2.1	0.5	0.1	0.4	0.0	0.3	10.3	1.2	30.6	23.6	1.2	0.0	2.6	0.4	0.4	213.8	9.7	2.4	3.8	0.2	16.1	0.1	0.9	0.0	47.0	0.8	0.0	0.6	23.2	8.8	97.3	1.8	19.6	7.5	0.0	93.7	0.0	1.5	3.3	1.9	5.4	27.8	0.7	1.5	0.2	9.0	5.0	3.7	0.0	106.8	17.5	0.1	0.3	3.9	19.9	0.7	2.1	3.6	1.0	2.9
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108963484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 4.8"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;hTCEpi: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.0	0.0	1.6	0.0	1.5	0.1	0.0	1.8	2.5	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	80.6	0.3	5.1	1.4	0.0	0.0	1.0	0.2	0.8	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.7	0.0	0.0	0.3	17.8	2.5	0.1	1.8	0.0	0.0	0.4	0.0	3.5	3.1	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.9	0.6	1.4	0.1	0.1	0.7	0.1	0.7	0.5	0.0
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	359.3	123.1	17.3	72.3	29.5	1.7	318.2	27.8	27.5	1131.0	802.4	200.7	75.5	410.6	126.0	305.8	497.6	676.1	773.7	47.0	11.9	61.3	15.7	414.9	16.1	21.8	24.5	214.1	106.3	216.9	90.3	505.7	23.1	466.8	83.6	3.1	121.2	158.5	36.0	296.3	174.5	180.3	15.9	24.9	269.1	21.9	24.7	20.5	195.3	47.5	13.0	704.6	940.5	14.6	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	17.3	29.5	27.8	27.5	47.0	11.9	21.8	24.5	23.1	15.9	24.7	14.6	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869411-91947987	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Group enriched"	"Detected in many"	19	"granulocytes: 6.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Uncertain	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		12000000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	182.2	73.4	10.7	17.7	12.8	7.5	110.4	7.4	12.5	124.9	15.7	80.3	19.1	178.4	40.0	26.8	143.0	130.2	211.1	9.4	8.6	108.4	29.3	164.8	25.5	15.5	10.9	107.3	46.4	16.8	14.5	67.0	14.2	49.0	20.6	0.6	55.8	70.9	30.4	66.9	52.7	88.7	13.1	130.9	68.9	35.6	12.7	21.8	79.5	36.0	15.7	117.5	93.3	7.5	0.0	1.6	0.2	0.0	457.1	234.6	22.5	202.0	202.5	5.8	4.5	4.7	0.0	0.0	4.2	394.6	0.6	0.1	9.8	1.0	1.0	0.0	2.3	0.4	4.7	0.0	74.2	0.0	0.1	216.6	0.4	3.9	14.1	2.8	10.4	0.1	0.0	0.1	25.3	0.4	0.5	0.5	0.5	0.0	0.5	0.4	30.2	0.2	1.2	0.1	0.2	0.1	12.3	0.7	2.6	7.0	2.9	0.3	1.9	3.2	6.6	3.8	0.1	0.1	0.0	0.2	0.4	0.0	0.0	6.6	0.1	2.2	0.8	0.2	0.5	0.0	0.3	0.1	0.0	0.1	1.1	1.8	2.5	0.0	0.2	0.0	0.1	0.4	10.7	12.8	7.4	12.5	9.4	8.6	15.5	10.9	14.2	13.1	12.7	7.5	31.4	83.3	13.1	0.0	2.1	9.2	2.4	7.1	1.8	0.0	11.2	9.3	5.2	0.0	11.5	5.5	0.0	2.5	2.5	0.1	5.9	4.7	5.9	13.3	67.4	15.2	0.0	0.4	2.6	4.7	2.5	209.4	2.0	12.0	2.5	1.8	34.2	0.4	7.8	0.0	3.6	0.1	18.3	2.5	18.4	27.5	626.6	5.8	21.4	15.9	1.6	0.0	8.2	5.0	2.3	2.2	0.0	794.8	0.7	1.3	0.0	32.5	21.4	0.0	6.6	28.0	14.5	3.0	2.8	1.3	8.7	3.7	15.5	3.5	0.4	1.2
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944362-86947506	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 105.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 127.1;Muller glia cells: 90.3;Skeletal myocytes: 213.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 30.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 44.2;ASC diff: 29.3;BJ hTERT+: 59.8;HSkMC: 41.1;RH-30: 91.1"	"Low region specificity"	"Detected in all"							"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"		NA	NA		27000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (1.96e-5)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (3.59e-2)"	81.5	6.4	3.6	16.6	4.4	0.2	38.3	3.5	4.4	27.1	16.1	27.6	2.2	105.4	15.2	5.8	60.7	10.5	27.1	3.2	2.7	12.5	2.2	7.8	6.8	3.8	3.8	45.1	11.2	1.9	8.4	22.1	3.6	22.6	2.3	3.3	13.1	9.6	12.2	22.2	9.3	43.4	3.4	3.6	16.3	1.8	3.8	7.1	15.9	9.3	3.1	22.5	27.1	6.8	0.0	0.0	7.5	44.2	29.3	10.9	0.8	8.8	59.8	2.9	2.6	0.0	0.1	0.0	0.5	15.8	0.3	0.6	0.0	0.3	1.2	5.2	17.8	0.0	25.0	0.0	14.9	0.1	0.7	41.1	6.3	1.0	5.3	0.0	0.0	0.9	0.0	0.0	12.6	0.0	0.0	0.4	9.5	0.3	0.1	9.6	91.1	0.0	0.4	0.0	1.0	4.0	12.9	0.0	14.1	4.8	0.1	0.2	0.1	13.0	3.6	0.9	3.0	0.0	0.0	0.0	0.4	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.4	3.5	4.4	3.2	2.7	3.8	3.8	3.6	3.4	3.8	6.8	15.8	0.0	0.6	2.0	0.4	25.9	7.5	10.9	10.2	8.3	3.9	28.3	5.5	0.0	3.1	14.7	10.4	21.5	7.8	0.1	9.8	0.5	0.1	2.4	36.6	5.6	0.0	0.4	1.2	0.4	3.7	127.1	1.1	2.0	0.0	2.1	22.9	0.3	5.8	5.0	2.6	0.3	0.0	1.0	15.4	0.9	32.3	2.2	17.8	1.9	0.2	90.3	7.2	8.5	4.4	0.2	0.0	12.4	2.1	4.5	0.0	2.6	0.7	3.2	39.5	213.7	15.4	0.3	1.3	1.0	12.5	4.5	2.1	0.8	0.2	0.4
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cell line enriched"	"Detected in many"	9	"WM-115: 533.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	27.3	8.5	34.9	23.7	68.9	31.1	15.3	75.4	79.8	29.9	0.0	26.3	7.3	13.3	4.3	23.8	17.8	16.3	46.1	61.9	8.4	1.7	2.3	17.1	9.1	23.4	24.1	7.8	3.4	1.1	2.6	16.2	15.8	8.5	12.0	30.1	7.8	10.8	5.8	33.7	11.9	24.0	14.3	16.1	8.9	17.4	32.9	9.3	4.6	6.8	10.3	18.3	19.5	85.3	0.1	0.5	0.6	1.0	16.5	22.5	0.3	0.8	0.0	2.6	1.1	0.1	0.2	6.6	1.9	6.6	0.3	0.3	0.0	0.0	1.6	0.0	1.5	0.0	1.3	0.7	5.3	1.8	48.7	4.3	0.3	5.1	0.1	0.0	0.0	42.7	0.0	0.6	0.0	0.0	54.3	15.4	2.6	2.1	0.0	14.3	0.1	49.6	0.0	0.2	0.1	3.0	0.2	0.2	60.1	21.0	2.8	24.7	0.0	0.2	3.4	0.1	0.1	0.4	0.0	0.0	0.4	35.1	533.8	0.6	26.2	17.1	2.8	6.9	0.9	0.5	0.3	1.4	5.3	0.6	0.2	1.4	16.4	4.5	4.9	1.0	0.0	7.7	34.9	68.9	75.4	79.8	61.9	8.4	23.4	24.1	15.8	14.3	32.9	85.3	2.9	0.0	4.2	6.8	3.3	8.3	4.5	1.5	1.2	34.6	1.6	2.3	13.3	0.0	1.1	5.5	27.1	1.0	14.5	0.0	0.0	1.0	62.3	17.7	12.8	5.7	0.0	0.4	133.6	0.0	1.8	79.6	0.0	26.3	17.2	7.9	5.0	0.9	39.2	0.0	76.6	0.0	0.0	66.7	32.2	73.4	10.2	54.3	33.8	52.5	57.2	9.5	18.6	11.1	163.3	0.2	0.0	1.9	5.5	2.0	0.0	0.1	16.3	31.7	0.0	67.0	7.1	1.6	6.7	1.0	16.6	1.9	7.4	0.2	0.0	4.9
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300197-47313577	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 19.6;retina: 18.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 20.9;Cone photoreceptor cells: 16.7;Fibroblasts: 25.7;Rod photoreceptor cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.5;MOLT-4: 3.0;SH-SY5Y: 5.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	12.4	3.2	5.4	0.3	5.4	0.0	9.7	5.1	4.0	2.6	0.6	2.5	0.0	4.2	0.2	2.4	1.6	2.2	4.4	5.9	3.3	0.1	0.1	19.6	0.8	2.6	5.8	0.3	13.3	0.0	0.7	0.0	1.4	2.2	0.3	18.4	8.8	0.2	2.2	3.1	0.6	0.4	2.5	0.1	1.8	7.1	5.5	0.4	9.7	10.4	1.0	1.3	1.7	3.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.4	5.1	4.0	5.9	3.3	2.6	5.8	1.4	2.5	5.5	3.7	2.4	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.0	20.9	0.1	0.0	0.8	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.2	25.7	0.0	0.0	1.3	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	2.6	0.7	0.9	0.2	1.8	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.6	1.6	0.4	1.3	0.0	0.9	0.0	0.4	0.0	0.0	0.0
GPNMB	"HGFIN, NMB"	ENSG00000136235	"Glycoprotein nmb"	Q14956	7	23235967-23275108	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 581.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 327.1;Fibroblasts: 285.8;Hofbauer cells: 814.1;Macrophages: 328.9;Melanocytes: 597.7;Suprabasal keratinocytes: 359.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 354.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.1;intermediate monocyte: 3.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.9"	"Cell line enriched"	"Detected in many"	6	"ASC diff: 5015.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 9.7"	"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		33000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.82e-1)"	"unprognostic (6.95e-2)"	152.9	25.9	20.9	41.7	20.9	6.6	135.6	19.0	70.9	303.9	77.6	78.8	22.5	180.9	43.8	111.8	72.8	270.7	323.5	21.2	23.1	32.7	52.5	215.8	169.0	32.2	21.5	77.7	20.6	15.3	12.8	148.6	31.0	30.4	92.9	2.9	66.1	55.8	15.4	581.2	48.5	151.5	27.3	31.9	37.1	26.2	34.6	89.5	51.5	72.4	103.4	190.9	151.0	66.5	19.2	0.8	0.1	0.6	5015.0	908.0	0.4	33.6	564.1	27.9	116.2	0.2	0.8	0.7	1.4	109.5	49.1	118.3	0.7	0.7	14.2	1.3	1.3	0.1	0.9	2.5	61.5	1.5	0.6	630.3	134.8	46.3	4.7	734.9	0.3	1.4	0.3	0.6	150.2	3.5	0.7	0.7	0.6	0.5	0.5	0.4	1.4	7.6	71.2	443.4	2.4	0.6	0.1	175.6	841.5	1.3	2.3	2.8	0.1	163.0	17.8	297.8	5.5	5.1	8.6	1.2	56.3	2.6	166.1	0.6	2.1	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.0	0.5	20.9	20.9	19.0	70.9	21.2	23.1	32.2	21.5	31.0	27.3	34.6	66.5	18.0	19.2	24.3	0.3	3.2	327.1	7.1	58.5	150.2	0.4	6.6	24.5	204.2	2.8	16.0	75.4	0.0	7.2	2.2	0.1	3.9	0.6	3.0	2.5	44.0	15.0	0.0	0.0	0.5	0.8	4.6	285.8	12.2	2.5	22.7	0.1	4.6	5.1	814.1	1.7	1.2	0.0	12.2	188.4	100.7	5.5	129.8	328.9	597.7	12.2	3.2	0.2	1.0	55.8	0.1	0.6	0.0	108.0	10.2	1.9	0.0	1.2	3.4	0.6	0.0	20.6	53.4	3.9	1.4	65.3	359.7	28.9	5.7	0.1	0.0	11.9
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 145.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 31.6;non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 120.2"	"HPA008005, HPA075088"	Uncertain				"Secreted to blood"	NA	NA	199000000	300000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008005: AB_1851499, HPA075088: "	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	145.8	90.2	28.1	9.2	32.6	0.4	150.5	31.8	40.8	276.6	71.6	75.5	20.8	117.2	129.5	75.8	237.4	36.8	107.0	28.4	33.1	30.6	7.7	40.4	8.7	32.7	29.2	136.8	15.9	4.8	106.3	15.7	33.2	129.3	28.0	6.6	35.9	122.2	38.5	39.2	52.5	39.0	36.7	45.2	67.6	22.2	41.7	6.8	58.4	102.2	9.2	127.1	214.1	27.2	135.3	219.6	0.2	177.3	313.9	1163.6	0.8	476.9	683.3	126.9	69.0	23.2	294.7	0.0	68.5	1045.9	96.4	453.3	3.0	42.3	26.2	1.2	2.8	4.4	37.1	33.3	111.9	0.8	1.1	325.5	2.3	57.4	11.9	468.5	30.5	7.5	0.6	9.3	53.1	0.5	6.6	1.0	6.8	4.1	150.4	2.3	4.9	5.6	10.1	3.3	1.3	8.7	152.2	0.0	10.9	4.0	6.3	0.5	132.2	87.2	41.2	95.5	18.0	5.3	10.7	0.6	631.6	6.7	49.5	0.0	0.0	31.6	0.6	6.8	3.4	0.1	1.0	5.4	2.1	0.0	0.5	6.8	0.0	0.0	20.1	0.0	0.0	1.5	28.1	32.6	31.8	40.8	28.4	33.1	32.7	29.2	33.2	36.7	41.7	27.2	83.9	6.4	4.2	2.0	3.4	113.6	41.0	580.8	23.9	2.5	5.9	29.0	21.1	10.0	37.6	20.2	0.0	3.0	3.5	0.2	11.7	87.9	9.6	4.9	99.2	71.9	0.0	3.2	3.1	8.0	4.9	1360.5	30.5	2.5	0.0	2.3	116.4	0.8	7.6	0.0	3.6	0.3	50.8	6.8	122.8	32.6	1030.8	15.2	144.1	19.7	2.5	51.1	0.0	1.5	0.9	77.1	0.0	1495.9	9.6	94.9	0.0	15.2	13.9	2.8	1170.1	102.3	420.9	3.8	6.8	8.0	87.8	3.4	14.1	0.4	0.0	34.1
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39209116-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.2;Endometrial stromal cells: 78.1;Extravillous trophoblasts: 156.9;Fibroblasts: 113.0;Smooth muscle cells: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"myeloid DC: 6.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 255.1;HSkMC: 186.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	143.2	55.1	46.3	18.6	49.9	1.1	128.7	59.2	45.2	51.6	57.2	51.7	10.8	78.8	47.5	37.0	88.9	74.5	99.7	45.6	57.3	31.9	14.2	82.6	39.1	54.9	56.8	49.6	17.2	18.2	26.9	134.6	51.4	30.8	16.7	11.9	34.7	36.9	32.1	37.9	29.0	68.9	47.8	30.4	27.9	20.4	64.3	17.0	64.2	89.2	17.6	49.1	48.3	44.3	11.5	4.0	118.3	5.1	255.1	115.1	51.6	61.8	88.3	30.8	23.1	0.5	11.6	17.5	1.3	86.6	40.0	17.3	15.0	36.2	25.3	16.9	17.2	47.3	3.7	0.0	26.7	0.8	0.9	186.4	4.7	27.7	45.7	27.6	29.1	1.1	0.0	0.1	59.9	9.9	0.0	14.5	8.8	0.2	15.8	7.7	51.3	0.1	20.9	15.0	0.7	3.8	5.6	7.2	16.8	67.4	6.7	0.1	54.3	77.9	11.7	24.4	33.9	0.9	0.0	48.9	32.4	0.2	57.2	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.3	46.3	49.9	59.2	45.2	45.6	57.3	54.9	56.8	51.4	47.8	64.3	44.3	195.2	3.2	12.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.4	28.6	0.0	0.0	9.9	0.0	0.0	5.0	1.4	0.0	1.9	0.6	0.0	2.7	78.1	32.0	0.0	0.0	0.0	0.6	156.9	113.0	0.0	2.8	2.5	22.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	3.6	2.2	0.0	0.0	0.0	131.6	0.0	0.0	0.0	0.0	6.2	1.2	45.8	0.0	0.0
NPR2	"AMDM, ANPb, ANPRB, GUCY2B, NPRB"	ENSG00000159899	"Natriuretic peptide receptor 2"	P20594	9	35791591-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Excitatory neurons: 69.1;Inhibitory neurons: 68.9;Microglial cells: 34.7;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.9;ASC TERT1: 21.1;BJ hTERT+: 20.2;HHSteC: 20.1;HSkMC: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.93e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.59e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.99e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.86e-2)"	12.4	8.2	9.3	1.7	9.4	0.3	10.3	14.4	9.9	25.7	7.7	15.6	1.8	20.5	8.7	3.2	15.1	3.2	12.8	9.1	11.4	6.7	8.6	9.1	2.3	11.8	9.4	9.4	3.2	1.3	13.8	4.7	11.5	10.9	2.8	4.1	5.3	6.5	10.8	8.3	7.5	9.9	8.2	4.9	7.8	4.8	10.7	2.2	6.0	8.6	1.7	12.1	14.7	7.9	0.0	2.9	2.2	0.0	30.9	21.1	1.9	9.3	20.2	7.0	6.4	4.5	4.3	1.8	3.0	17.9	12.8	1.2	3.6	0.2	6.1	2.2	1.0	1.8	4.3	3.4	20.1	0.4	0.0	23.8	1.8	8.9	0.6	7.6	12.7	2.5	0.7	0.2	13.4	1.0	0.5	0.8	3.5	1.0	3.7	2.4	0.2	0.5	1.8	1.4	1.1	0.7	0.4	0.1	0.6	3.8	0.2	0.0	8.2	8.5	7.8	3.2	1.2	0.5	0.6	4.8	10.4	0.6	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	9.3	9.4	14.4	9.9	9.1	11.4	11.8	9.4	11.5	8.2	10.7	7.9	2.7	3.2	3.4	35.6	0.0	1.1	0.6	0.6	1.2	5.1	0.7	1.4	0.7	1.5	0.3	0.0	2.1	0.4	0.5	0.7	0.0	0.6	0.3	1.4	9.2	4.4	0.0	0.0	69.1	0.8	0.2	7.2	0.5	2.0	1.3	9.6	6.1	4.5	0.4	3.3	68.9	0.7	0.0	0.3	2.1	0.3	9.3	0.3	0.0	34.7	0.0	6.8	0.0	51.8	16.3	0.6	3.6	7.9	0.2	2.7	0.2	0.6	1.1	2.2	0.0	5.1	3.4	4.5	3.1	0.1	1.6	0.3	0.7	0.8	1.1	0.4
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 136.6;Fibroblasts: 246.9;Leydig cells: 73.3;Theca cells: 126.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 577.3;ASC TERT1: 312.6;BJ hTERT+: 374.8;HSkMC: 581.6;LHCN-M2: 602.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		3000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	85.6	42.6	5.7	24.9	7.4	0.9	89.7	7.2	12.4	170.6	8.2	71.9	15.1	124.7	42.6	26.6	96.3	95.0	56.6	5.4	6.7	34.1	36.3	55.4	12.0	9.8	7.7	177.4	35.2	9.9	17.9	111.8	8.6	42.9	34.5	0.2	16.7	73.8	10.3	37.6	32.3	94.6	9.2	9.9	48.4	9.3	9.7	8.9	21.8	38.2	14.9	71.1	98.8	11.2	0.0	19.7	9.7	0.1	577.3	312.6	0.6	77.1	374.8	26.5	85.3	25.2	0.2	0.0	4.1	222.4	0.2	0.0	3.2	0.3	4.0	0.0	0.0	0.0	0.1	19.3	149.6	0.2	0.0	581.6	0.0	37.2	0.5	10.7	2.1	0.0	0.0	0.1	602.3	0.3	0.2	0.4	45.8	0.0	0.7	0.1	142.6	0.3	0.0	0.0	0.3	5.4	0.1	0.2	10.5	143.3	224.6	0.9	1.8	14.9	27.6	5.9	0.0	0.2	0.1	0.0	7.3	0.0	94.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	7.4	7.2	12.4	5.4	6.7	9.8	7.7	8.6	9.2	9.7	11.2	13.6	0.0	3.7	0.0	0.4	13.0	0.2	0.0	0.6	0.0	2.1	2.9	1.4	4.3	0.8	1.8	0.0	6.8	1.1	0.2	0.0	0.8	2.9	6.2	136.6	9.5	6.0	0.0	0.0	0.0	4.9	246.9	5.6	3.5	1.3	0.3	45.7	0.5	33.3	0.0	0.0	0.6	0.0	5.9	22.7	1.7	73.3	15.5	12.4	16.9	0.6	0.0	0.0	0.0	0.1	0.3	0.1	33.1	0.2	0.7	0.0	0.5	0.0	0.1	0.0	44.8	28.0	0.3	0.4	1.2	11.5	12.4	2.6	126.1	0.2	0.2
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92412380-92424471	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 66.8;Hepatic stellate cells: 26.4;Leydig cells: 97.9;Peritubular cells: 110.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"ASC diff: 6.1;ASC TERT1: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		21000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: AB_2732144"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	13.9	6.9	2.4	0.3	3.2	0.2	12.6	3.0	6.0	15.5	4.1	4.8	0.8	7.6	7.5	4.3	9.4	8.1	20.0	2.4	2.3	1.9	1.1	4.6	0.9	2.3	2.4	12.0	1.7	0.8	3.9	2.8	2.5	5.0	1.9	0.1	2.2	3.4	1.3	3.3	3.2	8.4	2.3	0.4	4.4	3.1	2.4	0.9	8.9	11.3	2.8	5.5	3.9	2.2	0.0	0.0	0.0	0.0	6.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.4	0.4	0.4	0.0	0.3	0.6	0.5	0.2	0.2	0.1	0.3	0.5	0.4	2.4	3.2	3.0	6.0	2.4	2.3	2.3	2.4	2.5	2.3	2.4	2.2	4.4	0.0	0.0	0.0	0.3	2.7	0.4	0.1	0.0	0.9	0.1	0.1	1.3	4.3	0.6	1.8	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.3	11.4	7.8	0.0	0.0	1.7	0.0	0.2	66.8	2.0	0.3	0.0	0.1	26.4	0.0	0.3	0.0	1.5	0.0	0.0	0.3	3.3	3.2	97.9	0.2	1.8	9.4	0.0	0.0	0.0	1.0	1.6	0.0	0.0	110.2	0.8	0.2	0.0	0.1	0.0	1.6	0.0	2.2	2.9	0.2	0.1	0.3	2.7	0.0	0.4	0.1	0.0	0.2
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	34.1	4.2	2.5	3.9	3.5	0.2	51.9	2.8	3.0	27.8	1.9	9.0	0.9	15.8	10.3	3.0	23.3	13.4	11.1	2.3	2.3	1.3	0.7	4.7	1.2	2.7	2.6	42.9	6.9	9.0	7.4	9.0	2.5	5.4	3.1	0.6	13.1	6.7	18.4	11.0	2.6	26.0	2.4	0.8	6.2	6.5	2.9	3.8	33.0	38.0	2.0	6.5	12.0	3.3	0.0	17.7	1.0	189.4	5.6	2.5	13.8	4.6	159.1	7.5	31.3	1.0	0.2	0.0	0.9	2.5	24.7	0.0	11.6	0.9	3.7	0.2	14.5	0.0	5.3	4.1	14.6	0.0	0.0	86.9	0.1	9.2	0.1	0.0	13.0	1.6	0.0	2.4	1.1	12.5	0.2	0.4	9.9	0.7	3.6	0.0	0.2	0.4	1.0	11.4	0.6	1.2	1.4	1.7	3.3	11.4	0.6	0.0	2.6	0.2	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.5	2.8	3.0	2.3	2.3	2.7	2.6	2.5	2.4	2.9	3.3	15.5	0.0	3.6	2.3	0.3	13.3	0.5	4.3	0.6	0.6	2.9	3.3	4.5	1.5	2.8	0.0	0.0	14.9	0.7	0.4	0.0	4.1	36.0	2.4	5.4	4.1	1.2	0.0	1.1	7.1	19.9	186.2	0.5	4.7	0.0	0.3	1.4	0.2	3.5	0.0	3.5	1.3	2.0	0.0	14.6	6.7	74.6	1.6	10.6	1.9	1.6	1.4	0.0	3.0	1.3	3.1	0.1	70.7	0.2	1.9	0.4	0.1	0.2	0.4	0.0	8.0	10.7	0.8	1.9	0.6	9.9	9.7	1.7	1.5	0.4	0.5
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036913-36124455	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		64000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	14.7	7.4	3.0	4.6	3.3	1.2	13.7	3.4	4.3	15.2	2.7	6.8	3.7	14.4	6.1	11.7	8.0	13.7	8.5	4.6	3.3	5.7	5.8	12.7	5.8	3.4	3.1	14.3	3.2	3.7	3.1	11.3	3.5	8.3	6.3	4.7	4.7	7.3	3.7	7.6	5.1	14.7	3.1	7.3	5.7	3.2	3.4	6.6	6.2	16.0	4.4	12.1	7.5	4.0	1.4	2.4	8.0	4.4	199.5	158.5	0.1	65.1	93.0	4.7	11.0	0.0	0.0	2.5	6.0	57.8	3.7	0.4	1.8	1.2	6.4	4.1	3.7	2.6	2.8	0.2	16.2	0.3	11.1	71.3	1.6	7.1	2.7	18.4	14.6	4.8	0.0	2.1	12.2	0.3	6.6	1.0	2.7	0.0	2.0	6.9	6.2	0.0	3.2	0.2	0.7	4.5	1.5	0.8	2.7	8.3	0.0	8.9	44.4	9.0	3.3	5.9	3.6	2.9	3.4	2.7	5.5	8.7	5.8	1.0	2.6	0.7	3.9	2.8	4.4	1.2	5.2	4.2	2.9	2.7	6.3	4.6	0.3	3.0	4.8	1.6	2.6	2.3	3.0	3.3	3.4	4.3	4.6	3.3	3.4	3.1	3.5	3.1	3.4	4.0	12.8	3.2	5.4	40.1	11.7	7.1	4.0	5.0	4.6	12.5	4.2	5.6	3.6	1.5	2.5	3.7	14.6	0.9	9.3	0.2	0.0	6.6	38.3	0.9	11.6	19.6	6.1	5.7	63.1	1.5	7.7	53.4	3.6	0.6	9.5	9.2	25.4	1.1	15.6	8.4	71.1	1.3	4.1	15.7	15.9	35.5	18.6	8.3	3.6	41.2	8.8	14.3	2.1	80.4	119.8	1.3	0.4	17.7	5.9	4.3	0.3	1.6	4.1	7.8	0.0	14.2	15.3	41.2	27.4	1.3	7.5	0.8	10.2	7.8	0.8	1.2
TENT5A	"C6orf37, FAM46A, FLJ20037"	ENSG00000112773	"Terminal nucleotidyltransferase 5A"	Q96IP4	6	81491439-81752774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 225.9;salivary gland: 104.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	13.5	21.3	4.3	7.9	4.6	225.9	12.2	9.0	5.8	21.3	9.9	17.2	16.4	10.2	19.7	4.4	12.0	32.3	21.7	4.0	14.0	6.4	35.9	9.1	5.2	7.8	7.1	23.6	8.3	9.4	17.4	18.7	6.1	9.9	16.9	8.7	104.4	24.8	2.1	18.7	22.2	11.1	5.0	9.9	37.8	3.7	6.7	2.9	8.8	5.1	4.3	16.6	8.8	5.3	3.5	5.0	3.3	0.2	67.9	29.8	6.2	27.0	19.2	15.7	23.5	51.0	2.6	0.3	1.0	81.9	10.0	2.9	2.4	4.2	11.5	0.0	6.2	0.1	86.1	8.0	21.2	95.6	7.1	13.2	2.4	12.3	2.1	51.2	2.0	0.8	1.4	0.0	10.6	14.7	0.0	67.2	0.9	29.2	3.8	0.0	28.8	0.1	2.1	6.2	3.3	4.4	12.1	5.2	8.3	9.9	1.2	162.0	4.5	17.9	3.8	7.6	7.6	0.4	0.3	0.3	25.3	72.7	7.8	37.3	29.9	46.3	11.5	29.6	6.8	18.2	4.3	5.7	24.2	21.0	8.1	8.0	13.8	16.9	47.3	8.5	5.6	14.0	4.3	4.6	9.0	5.8	4.0	14.0	7.8	7.1	6.1	5.0	6.7	5.3	22.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	40.8	44.2	0.0	0.0	0.0	5.5	0.0	39.9	43.1	0.0	3.9	30.5	0.0	73.1	70.6	2.9	0.0	0.0	0.0	23.4	115.4	32.7	0.0	176.7	0.0	40.9	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	26.7	0.0	0.0	5.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	162.0	9.4	12.6	0.0	0.0
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 941.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 475.9;Late spermatids: 491.0;Leydig cells: 353.6;Peritubular cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.6;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1327.4;ASC TERT1: 1618.4;BJ hTERT+: 960.2;fHDF/TERT166: 1070.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	461.0	185.1	171.5	92.3	140.8	20.1	290.6	110.6	122.1	576.3	117.9	280.5	71.0	525.4	116.8	176.0	272.7	397.9	244.8	128.6	157.0	120.7	62.8	231.7	77.7	157.4	161.5	941.0	79.1	64.0	103.6	218.1	156.2	196.2	107.6	43.5	107.2	267.5	56.6	245.2	149.5	381.6	141.5	172.0	140.9	150.4	178.0	80.0	155.6	119.8	38.7	261.2	331.0	168.1	170.0	84.0	93.0	178.8	1327.4	1618.4	50.2	585.0	960.2	280.1	221.1	30.8	288.6	0.2	200.8	1070.2	307.4	32.9	29.1	25.2	291.4	3.4	16.6	0.1	156.0	48.1	392.7	2.6	1.2	641.1	12.0	276.8	44.3	722.5	375.9	54.4	0.2	0.5	292.5	19.5	176.8	29.7	16.6	34.2	122.8	118.0	213.2	73.4	178.7	2.3	47.6	290.3	366.6	170.8	776.3	111.6	86.8	42.2	450.3	744.2	140.5	438.0	102.8	84.1	74.9	1.5	171.0	32.0	367.6	0.0	5.0	7.4	0.0	3.4	0.0	0.1	0.1	0.0	2.2	0.2	0.2	0.3	13.6	0.2	4.3	1.4	0.1	0.9	171.5	140.8	110.6	122.1	128.6	157.0	157.4	161.5	156.2	141.5	178.0	168.1	147.9	112.2	34.3	24.2	18.7	98.9	9.0	5.7	9.1	37.5	9.7	37.6	41.9	52.9	20.8	25.8	8.4	4.3	6.1	46.0	0.0	78.0	143.7	17.0	190.3	115.0	7.8	12.4	9.8	22.0	87.7	475.9	17.9	24.4	7.0	97.5	259.5	7.9	208.8	3.3	107.7	14.3	12.2	177.4	171.4	491.0	353.6	184.8	275.7	96.5	87.3	39.9	5.2	60.8	143.5	83.3	6.0	770.7	33.1	10.1	12.8	0.8	5.4	12.7	92.1	111.8	171.9	8.5	7.7	5.6	75.9	14.8	17.5	96.0	2.3	6.9
ZFHX4	"FLJ20980, ZFH4"	ENSG00000091656	"Zinc finger homeobox 4"	Q86UP3	8	76681239-76867281	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 358.5;Bipolar cells: 87.2;Oligodendrocyte precursor cells: 234.2;Oligodendrocytes: 222.6;Skeletal myocytes: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 16.8;TIME: 33.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023837	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA023837: AB_1859013"	"unprognostic (2.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.63e-3)"	"unprognostic (6.14e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.15e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.20e-7)"	"unprognostic (3.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.50e-4)"	"unprognostic (5.89e-4)"	3.0	3.6	7.5	0.5	12.0	0.0	2.1	0.9	9.3	3.2	0.0	3.2	0.0	0.8	3.2	0.3	0.6	0.9	0.4	6.0	18.9	0.3	2.8	0.1	0.3	11.3	23.3	1.9	0.2	0.2	2.8	0.1	17.7	1.0	0.5	2.2	0.6	5.5	2.8	0.4	0.3	1.1	7.0	0.1	0.8	6.7	15.3	0.6	0.3	3.1	0.0	2.7	2.6	15.0	0.0	2.2	3.8	0.0	7.2	8.7	0.0	3.3	4.6	3.8	3.9	0.0	0.0	0.0	5.8	5.7	1.7	0.4	7.8	1.0	7.6	0.0	10.3	0.1	0.0	0.0	1.9	0.0	0.5	16.8	0.4	9.5	3.0	6.5	0.7	0.0	0.1	0.3	7.0	0.0	0.0	0.0	0.6	0.4	7.1	0.0	6.8	0.0	5.8	0.0	0.0	6.5	0.0	0.8	0.0	0.0	0.9	0.0	33.4	3.7	5.6	10.6	7.4	10.9	1.2	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	12.0	0.9	9.3	6.0	18.9	11.3	23.3	17.7	7.0	15.3	15.0	5.4	0.0	1.5	358.5	0.3	0.5	0.1	1.0	2.2	87.2	2.4	2.2	4.0	42.9	0.3	5.5	2.1	0.1	0.2	0.0	0.0	0.1	70.0	0.0	1.1	2.0	0.0	0.0	13.7	0.0	0.0	37.5	0.0	0.0	0.0	0.1	1.1	30.5	0.4	5.0	12.6	0.2	0.0	0.6	1.8	24.3	13.7	0.7	0.0	29.0	0.0	15.0	0.0	234.2	222.6	0.0	0.0	21.4	0.1	0.3	0.0	0.3	0.3	5.8	0.0	120.6	8.1	12.4	2.3	1.2	1.1	0.0	0.6	10.0	0.0	0.9